CSIMarket Company Name, Ticker, Suppliers, else..
 

Revolution Medicines Inc   (NASDAQ: RVMD)

Revolution Medicines Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

RVMD Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Revolution Medicines Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 6.85 %, recorded in the same quarter.

• List of RVMD Competitors





Revenue Growth Comparisons




Net Income Comparison

Revolution Medicines Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  RVMD Stock Performance Comparisons





*Market share is calculated based on total revenue.

  News about Revolution Medicines Inc Contracts

Revolution Medicines Unveils Groundbreaking RAS Inhibitor with Unprecedented Anti-Tumor Activity in Pancreatic Cancer Models

April 8, 2024
 Revolution Medicines Announces Groundbreaking Discovery and Preclinical Profile of New Class of RAS(ON) Multi-Selective Inhibitors with Unprecedented Anti-Tumor Activity in RAS-Mutant Pancreatic Cancer ModelsRevolution Medicines, a leading biotechnology company focused on developing innovative cancer treatments, has recently made significant progress in the field of oncology. In a press release issued today, the company announced the publication of two original papers in the prestigious scientific journal Nature, showcasing the discovery and translational implications of their latest breakthrough compound, RMC-7977.RMC-7977 is a RAS(ON) multi-selective tri-complex inhibitor, specifically designed to block th...





Publicly Traded Peers of Revolution Medicines Inc




Springworks Therapeutics Inc
Share Performance



+21.96%
One Year
Springworks Therapeutics Inc
Profile

Springworks Therapeutics Inc is a biopharmaceutical company with a focus on developing innovative medicines for underserved patient populations. Their business model revolves around identifying promising therapeutic candidates, which could address significant unmet needs, and advancing them through various stages of clinical development. They collaborate with academic institutions, research organizations, and industry partners to accelerate the discovery and development of potential treatments, ultimately aiming to bring these therapies to market and improve patient outcomes.

More about Springworks Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,518.860 mill. $ 219.670 mill. $ -258.131 mill.


Sutro Biopharma Inc
Share Performance



-19.14%
30 Days
Sutro Biopharma Inc
Profile

Sutro Biopharma Inc has a business model focused on developing and commercializing innovative antibody-based therapeutics.

More about Sutro Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 274.426 mill. $ 45.702 mill. $ -180.636 mill.


Scinai Immunotherapeutics Ltd
Share Performance



+533.74%
30 Days
Scinai Immunotherapeutics Ltd
Profile

The company develops therapeutics and operates as a contract development and manufacturing organization (CDMO).

More about Scinai Immunotherapeutics Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 1.311 mill. $ -8.307 mill.


Sab Biotherapeutics Inc
Share Performance



-6.06%
Over The Past 5 Days
Sab Biotherapeutics Inc
Profile

Sab Biotherapeutics Inc's business model focuses on developing and producing innovative antibody therapeutics using advanced genetic engineering techniques.

More about Sab Biotherapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 271.958 mill. $ - mill. $ -12.775 mill.


Mosaic Immunoengineering Inc
Share Performance



0.00%
Over The Past 5 Days
Mosaic Immunoengineering Inc
Profile

Mosaic Immunoengineering Inc's business model revolves around leveraging cutting-edge technologies and expertise in immunoengineering to develop innovative solutions and therapies for immune-related diseases.

More about Mosaic Immunoengineering Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.037 mill. $ - mill. $ -0.687 mill.

51 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Revolution Medicines Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Revolution Medicines Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.